A phase 2, multicenter, placebo-controlled study of single-dose squaric acid dibutyl ester to reduce frequency of outbreaks in patients with recurrent herpes labialis

Subjects

Subjects :

medicine.medical_specialty
business.industry
Placebo-controlled study
Outbreak
Dermatology
Squaric acid
Gastroenterology
chemistry.chemical_compound
chemistry
Recurrent herpes labialis
Internal medicine
Medicine
In patient
business

Details

ISSN :

01909622

Volume :

83

Database :

OpenAIRE

Journal :

Journal of the American Academy of Dermatology

Accession number :

edsair.doi...........ab5bcc9a7b7bcf296fa4b866b5238c99

Full Text :

https://doi.org/10.1016/j.jaad.2020.04.021